Greenberg F, Guzzetta V, Montes de Oca-Luna R, Magenis R E, Smith A C, Richter S F, Kondo I, Dobyns W B, Patel P I, Lupski J R
Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Am J Hum Genet. 1991 Dec;49(6):1207-18.
We undertook clinical evaluation (32 cases) and molecular evaluation (31 cases) of unrelated patients affected with Smith-Magenis syndrome (SMS) associated with an interstitial deletion of band p11.2 of chromosome 17. Patients were evaluated both clinically and electrophysiologically for peripheral neuropathy, since markers showing close linkage to one form of Charcot-Marie-Tooth disease (CMT1A) map to this chromosomal region. The common clinical findings were broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay, and hoarse, deep voice. Fifty-five percent of the patients showed clinical signs (e.g., decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass) suggestive of peripheral neuropathy. However, unlike patients with CMT1A, these patients demonstrated normal nerve conduction velocities. Self-destructive behaviors, primarily onychotillomania and polyembolokoilamania, were observed in 67% of the patients, and significant symptoms of sleep disturbance were observed in 62%. The absence of REM sleep was demonstrated by polysomnography in two patients. Southern analysis indicated that most patients were deleted for five 17p11.2 markers--FG1 (D17S446), 1516 (D17S258), pYNM67-R5 (D17S29), pA10-41 (D17S71), and pS6.1-HB2 (D17S445)--thus defining a region which appears to be critical to SMS. The deletion was determined to be of paternal origin in nine patients and of maternal origin in six patients. The apparent random parental origin of deletion documented in 15 patients suggests that genomic imprinting does not play a role in the expression of the SMS clinical phenotype. Our findings suggest that SMS is likely a contiguous-gene deletion syndrome which comprises characteristic clinical features, developmental delay, clinical signs of peripheral neuropathy, abnormal sleep function, and specific behavioral anomalies.
我们对32例患有与17号染色体p11.2带间质性缺失相关的史密斯-马吉尼斯综合征(SMS)的非亲属患者进行了临床评估,并对31例患者进行了分子评估。由于显示与一种遗传性运动感觉神经病1型(CMT1A)紧密连锁的标记定位于该染色体区域,因此对患者进行了外周神经病变的临床和电生理评估。常见的临床发现包括中面部宽阔扁平、短头畸形、鼻梁宽阔、短指畸形、语言发育迟缓以及声音嘶哑、低沉。55%的患者表现出提示外周神经病变的临床体征(如,跟腱反射减弱或消失、扁平足或高弓足、疼痛敏感性降低以及腿部肌肉量减少)。然而,与CMT1A患者不同,这些患者的神经传导速度正常。67%的患者出现自伤行为,主要是拔甲癖和抠挖皮肤行为,62%的患者出现明显的睡眠障碍症状。两名患者经多导睡眠图检查显示无快速眼动睡眠。Southern印迹分析表明,大多数患者缺失了五个17p11.2标记——FG1(D17S446)、1516(D17S258)、pYNM67-R5(D17S29)、pA10-41(D17S71)和pS6.1-HB2(D17S445)——从而确定了一个似乎对SMS至关重要的区域。在9例患者中确定缺失源自父方,在6例患者中源自母方。15例患者中缺失的明显随机亲本来源表明,基因组印记在SMS临床表型的表达中不起作用。我们的研究结果表明,SMS可能是一种连续性基因缺失综合征,其包括特征性临床特征、发育迟缓、外周神经病变的临床体征、异常睡眠功能以及特定行为异常。